
Tofogliflozin
CAS No. 903565-83-3
Tofogliflozin( CSG452 | CSG-452 )
Catalog No. M16493 CAS No. 903565-83-3
Tofogliflozin (CSG-452) is a potent, highly selective SGLT2 inhibitor with Ki of 2.9, 14.9, and 6.4 nM against human, rat, and mouse SGLT2, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTofogliflozin
-
NoteResearch use only, not for human use.
-
Brief DescriptionTofogliflozin (CSG-452) is a potent, highly selective SGLT2 inhibitor with Ki of 2.9, 14.9, and 6.4 nM against human, rat, and mouse SGLT2, respectively.
-
DescriptionTofogliflozin (CSG-452) is a potent, highly selective SGLT2 inhibitor with Ki of 2.9, 14.9, and 6.4 nM against human, rat, and mouse SGLT2, respectively; displays high selectivity over human SGLT2 versus human SGLT1, SGLT6, and sodium/myo-inositol transporter 1; increases renal glucose clearance and lowered the blood glucose level in Zucker diabetic fatty rats, also improves postprandial glucose excursion; reduces glycated hemoglobin and improved glucose tolerance in the oral glucose tolerance test in vivo.Diabetes Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsCSG452 | CSG-452
-
PathwayGPCR/G Protein
-
TargetSGLT
-
RecptorSGLT
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number903565-83-3
-
Formula Weight386.444
-
Molecular FormulaC22H26O6
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2
-
Chemical NameSpiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4',5'-triol, 6-[(4-ethylphenyl)methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)-, (1S,3'R,4'S,5'S,6'R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Suzuki M, et al. J Pharmacol Exp Ther. 2012 Jun;341(3):692-701.
2. Ohtake Y, et al. J Med Chem. 2012 Sep 13;55(17):7828-40.
3. Nagata T, et al. Am J Physiol Endocrinol Metab. 2013 Feb 15;304(4):E414-23.
4. Nagata T, et al. Br J Pharmacol. 2013 Oct;170(3):519-31.
molnova catalog



related products
-
Canagliflozin
A highly potent and selective SGLT2 inhibitor with IC50 of 4.4, 3.7 and 2.0 nM for hSGLT2, rSGLT2 and mSGLT2, respectively.
-
Leachianone A
Leachianone A is a potential antitoxic agent, it shows inhibitory effects on cadmium- Induced cytotoxicity.
-
Quinine HCl Dihydrat...
Quinine HCl Dihydrate is a white crystalline K+ channel blocker, used to treat malaria.